Unknown

Dataset Information

0

Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor ?.


ABSTRACT: Cyclooxygenase (COX)-2 selective inhibitors suppress non-alcoholic fatty liver disease (NAFLD); however, the precise mechanism of action remains unknown. The aim of this study was to examine how the COX-2 selective inhibitor nimesulide suppresses NAFLD in a murine model of high-fat diet (HFD)?induced obesity. Mice were fed either a normal chow diet (NC), an HFD, or HFD plus nimesulide (HFD-nime) for 12 weeks. Body weight, hepatic COX-2 mRNA expression and triglyceride accumulation were significantly increased in the HFD group. Triglyceride accumulation was suppressed in the HFD-nime group. The mRNA expression of hepatic peroxisome proliferator-activated receptor ? (PPAR?) and the natural PPAR? agonist 15-deoxy-?12,14-prostaglandin J2 (15d?PGJ2) were significantly increased in the HFD group and significantly suppressed in the HFD-nime group. Glucose metabolism was impaired in the HFD group compared with the NC group, and it was significantly improved in the HFD-nime group. In addition, the plasma insulin levels in the HFD group were increased compared with those in the NC group, and were decreased in the HFD-nime group. These results indicate that HFD-induced NAFLD is mediated by the increased hepatic expression of COX-2. We suggest that the production of 15d-PGJ2, which is mediated by COX-2, induces NAFLD and hepatic insulin resistance by activating PPAR?. Furthermore, the mRNA expression of tissue inhibitor of metalloproteinases-1 (TIMP?1), procollagen-1 and monocyte chemoattractant protein-1 (MCP-1), as well as the number of F4/80-positive hepatic (Kupffer) cells, were significantly increased in the HFD group compared with the NC group, and they were reduced by nimesulide. In conclusion, COX-2 may emerge as a molecular target for preventing the development of NAFLD and insulin resistance in diet-related obesity.

SUBMITTER: Tsujimoto S 

PROVIDER: S-EPMC4990319 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γ.

Tsujimoto Shunsuke S   Kishina Manabu M   Koda Masahiko M   Yamamoto Yasutaka Y   Tanaka Kohei K   Harada Yusuke Y   Yoshida Akio A   Hisatome Ichiro I  

International journal of molecular medicine 20160711 3


Cyclooxygenase (COX)-2 selective inhibitors suppress non-alcoholic fatty liver disease (NAFLD); however, the precise mechanism of action remains unknown. The aim of this study was to examine how the COX-2 selective inhibitor nimesulide suppresses NAFLD in a murine model of high-fat diet (HFD)‑induced obesity. Mice were fed either a normal chow diet (NC), an HFD, or HFD plus nimesulide (HFD-nime) for 12 weeks. Body weight, hepatic COX-2 mRNA expression and triglyceride accumulation were significa  ...[more]

Similar Datasets

| S-EPMC10048618 | biostudies-literature
| S-EPMC6850367 | biostudies-literature
| S-EPMC2884686 | biostudies-literature
| S-EPMC4047177 | biostudies-literature
| S-EPMC8229510 | biostudies-literature
| S-EPMC3781493 | biostudies-literature
| S-EPMC5735692 | biostudies-literature
| S-EPMC2651753 | biostudies-literature
| S-EPMC9777423 | biostudies-literature
| S-EPMC7408116 | biostudies-literature